Stokes Frank sold CSTL

March 3, 2026 · Form 4 insider transaction

Stokes Frank sold 3,611 shares of Castle Biosciences, Inc. at $27.57 per share, a transaction worth $99.6K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
3,611
Price
$27.57
Total value
$99.6K
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after48,872
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the delivery of vested performance stock units reported on January 12, 2026.

View the original Form 4 on SEC EDGAR